ARPEL Trademark
Trademark Overview
On Wednesday, March 20, 2002, a trademark application was filed for ARPEL with the United States Patent and Trademark Office. The USPTO has given the ARPEL trademark a serial number of 78116258. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Wednesday, March 26, 2003. This trademark is owned by Pfizer Inc.. The ARPEL trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, cancer, migraines, pain, obesity, inflammation and inflammatory diseases, respiratory and infectious diseases, and immunological, bacterial, viral and fungal disorders; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, tissue and skin repair preparations, dermatological preparations, and gynecological preparations; pharmaceutical preparation for the prevention and treatment of stroke and ischemia
General Information
| Serial Number | 78116258 |
| Word Mark | ARPEL |
| Filing Date | Wednesday, March 20, 2002 |
| Status | 605 - ABANDONED - EXPRESS AFTER PUB |
| Status Date | Wednesday, March 26, 2003 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, November 5, 2002 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, cancer, migraines, pain, obesity, inflammation and inflammatory diseases, respiratory and infectious diseases, and immunological, bacterial, viral and fungal disorders; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, tissue and skin repair preparations, dermatological preparations, and gynecological preparations; pharmaceutical preparation for the prevention and treatment of stroke and ischemia |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Wednesday, March 26, 2003 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Pfizer Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10017 |
| Party Name | Pfizer Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10017 |
Trademark Events
| Event Date | Event Description |
| Wednesday, March 26, 2003 | ABANDONMENT - AFTER PUBLICATION |
| Tuesday, January 21, 2003 | PAPER RECEIVED |
| Monday, December 16, 2002 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Tuesday, November 5, 2002 | PUBLISHED FOR OPPOSITION |
| Wednesday, October 16, 2002 | NOTICE OF PUBLICATION |
| Thursday, August 22, 2002 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, July 19, 2002 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, July 19, 2002 | PAPER RECEIVED |
| Thursday, July 11, 2002 | NON-FINAL ACTION MAILED |
| Wednesday, July 10, 2002 | ASSIGNED TO EXAMINER |
